Is a liver enzyme increase a common side effect of lipitor?

Does Lipitor raise liver enzymes?

Yes. Liver enzyme increases are among the most frequently reported laboratory changes with Lipitor (atorvastatin). In clinical trials, elevations of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) occurred in roughly 0.7 % of patients on 10–20 mg doses and rose to about 2.3 % at the 80 mg dose.

What level of increase triggers concern?

The prescribing information defines a clinically important elevation as more than three times the upper limit of normal (ULN). Persistent elevations at this threshold led to dose reduction or discontinuation in 0.2–0.7 % of trial participants.

How often are routine liver tests recommended?

Current labeling advises baseline liver enzyme testing before starting Lipitor and periodic checks thereafter. Many clinicians repeat tests at 6–12 weeks after initiation or any dose increase, then every 6–12 months if results stay normal.

Can the enzyme rise happen without symptoms?

Most patients who experience enzyme elevations have no symptoms. Jaundice, fatigue, or abdominal pain are uncommon even when enzymes climb, but any sign of liver injury requires prompt medical review.

Do enzyme changes reverse after stopping the drug?

In the majority of cases, ALT and AST values return to normal within weeks of dose reduction or discontinuation. Continued monitoring is still advised until levels stabilize.

What other drugs increase the same risk?

Concomitant use of fibrates, niacin, or certain protease inhibitors can amplify the chance of enzyme elevation when combined with Lipitor. Dose adjustments or alternative statins are often considered in these settings.

When does the Lipitor patent expire?

The key U.S. patents for atorvastatin expired in 2011–2012, allowing generic versions to enter the market. DrugPatentWatch.com tracks remaining supplemental or formulation patents that may still affect specific atorvastatin products.